Experts warn of 'zombie drug' xylazineXylazine, an animal tranquilizer, is increasingly involved in fatal overdoses, posing a severe health threat across cities.
Gavin Newsom says California lawmaker made 'big mistake' killing a drug bill. Why did it die?Gov. Newsom criticizes the killing of a bill restricting access to the street drug xylazine and expresses intent on ensuring its success.
Experts warn of 'zombie drug' xylazineXylazine, an animal tranquilizer, is increasingly involved in fatal overdoses, posing a severe health threat across cities.
Gavin Newsom says California lawmaker made 'big mistake' killing a drug bill. Why did it die?Gov. Newsom criticizes the killing of a bill restricting access to the street drug xylazine and expresses intent on ensuring its success.
Sixty Years Later, and Thalidomide Is Still With UsFrances Kelsey’s actions prevented thalidomide's U.S. approval, protecting many from its devastating impact seen globally.
Drugmakers to stop making controversial fentanyl lollipops, FDA saysThe FDA announced the discontinuation of controversial fentanyl painkillers due to their role in the opioid epidemic.
It's Not Just Big Pharma: Meet the Middlemen Blocking Access to MedicationPharmacy benefit managers (PBMs) are largely unregulated and significantly impact the access and cost of medications for patients.
Will the NHS ever pay for the new era of dementia drugs?The NHS has denied funding for lecanemab, the first drug shown to slow Alzheimer's progression, due to cost-effectiveness concerns.
Debate rages over Alzheimer's drug lecanemab as UK limits approvalThe debate over lecanemab centers on balancing its potential cognitive benefits against the risks and costs involved.
Will the NHS ever pay for the new era of dementia drugs?The NHS has denied funding for lecanemab, the first drug shown to slow Alzheimer's progression, due to cost-effectiveness concerns.
Debate rages over Alzheimer's drug lecanemab as UK limits approvalThe debate over lecanemab centers on balancing its potential cognitive benefits against the risks and costs involved.
Supreme court to hear abortion pill case that could restrict access to mifepristone liveConservative challengers targeting FDA decisions on mifepristone could impact access to other medications.Supreme court case on mifepristone could reshape abortion access and drug regulation in the US.
Safety fears over asthma drug after young children suffer severe side effectsFamilies report severe side effects from montelukast, including night terrors and suicidal behavior.Campaigners demand more prominent warnings, stricter controls, and support for those affected by montelukast.